Text Size

General Practitioners (GP) Involvement in Colorectal Cancer (CRC) Screening

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2011 by Paris 12 Val de Marne University.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
Paris 12 Val de Marne University
ClinicalTrials.gov Identifier:
NCT01364454
First received: May 31, 2011
Last updated: June 1, 2011
Last verified: May 2011
History of Changes

May 31, 2011
June 1, 2011
June 2010
June 2011   (final data collection date for primary outcome measure)
Patient's participation to colorectal cancer screening program [ Time Frame: 1 year ] [ Designated as safety issue: No ]

Patient's status with colorectal cancer screening program to 15th june 2011 with two modalities

  1. Update: completion of Faecal Occult Blood test or exclusion for medical reason within the duration of the study (The medical exclusions of the program are a personal or family history of Colorectal cancer, Crohn's disease, hemorrhagic rectocolitis, or hereditary nonpolyposis colorectal cancer, a colonoscopy undergone in the 5 previous years or a Fecal Occult Blood test undergone in the 2 previous years)
  2. Not update
Same as current
Complete list of historical versions of study NCT01364454 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
General Practitioners (GP) Involvement in Colorectal Cancer (CRC) Screening
Effect of Eligible Patients Paper-based Reminder for General Practitioners on Colorectal Cancer Screening Participation

Screening for ColoRectal Cancer (CRC) is widely recommended because of compelling evidence that it reduces mortality from CRC and that it's cost-effective. In France, there is a national CRC screening programme inviting people aged 50-74 years by mail to consult their General Practitioner (GP) for a free on charge Faecal Occult Blood test deliverance every two years. Participation is a key factor for the screening programs success. High levels of screening uptake and the continued participation to regular screening must be achieved and maintained in the targeted population if the enormous potential of CRC screening is to be realised. Screening rates of various international programs vary widely (20-52%) and the participation is insufficient in the most settings. Therefore, a better understanding of facilitating and hindering factors of patient participation can guide interventions to improve CRC screening rates. They include patients and physicians' factors. One issue is about GPs practice. GP involvement has been shown to improve the participation in the CRC screening. This study aims to assess the effectiveness of an intervention targeting GPs to increase patient participation in the CRC screening. Volunteer GPs will be randomly assigned to either the intervention group or to usual care (control group) and they will be followed one year. The intervention consists in providing every four months to the experimental group a list of their patients who are eligible but did not proceed yet to the screening. In both groups, patient participation in the screening will be measured at the end of the study.
Not Provided
Interventional
Phase 0
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Screening
Colorectal Cancer
Other: Eligible patients' paper-based reminder
Providing to the general practitioners every four months a list of their patients who are eligible for colorectal cancer screening but did not proceed yet and were not excluded for medical reason
Experimental: Eligible patients' paper-based reminder
Intervention: Other: Eligible patients' paper-based reminder
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
8140
June 2011
June 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  1. General Practitioner (GP)

    • exercising in the Val de Marne (French department of the suburb of Paris)
    • volunteered to participate at the study

  2. Patient

    • living in the Val de Marne (French department of the suburb of Paris)
    • having declared a 'preferred GP' exercising in the Val de Marne to the main statutory health insurance scheme ("régime général")
    • being eligible for colorectal cancer screening (aged 50 to 74 years, not excluded and having not proceed yet to the screening)
    • having consulted his 'preferred GP', whatever the reason, during the study period

Exclusion Criteria:
Both
50 Years to 74 Years
No
Contact information is only displayed when the study is recruiting subjects
France
 
NCT01364454
DUERMG
No
Julien Le Breton / PI, LIC EA4393 / DUERMG
Paris 12 Val de Marne University
Not Provided
Principal Investigator: Julien Le Breton, MD, MPH DUERMG
Paris 12 Val de Marne University
May 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP